BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2664975)

  • 1. [Neurologic involvement in campylobacter infections. 5 cases].
    Clavelou P; Beytout J; Gourdiat A; Garandeau A; Deffond D; Tournilhac M
    Rev Neurol (Paris); 1989; 145(3):208-14. PubMed ID: 2664975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome following Campylobacter jejuni enteritis. Report of three cases and review of the literature.
    Sovilla JY; Regli F; Francioli PB
    Arch Intern Med; 1988 Mar; 148(3):739-41. PubMed ID: 3277576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guillain-Barré syndrome following Campylobacter jejuni enteritis].
    Beenen LF; Scholten HG
    Ned Tijdschr Geneeskd; 1990 May; 134(20):1010-2. PubMed ID: 2348889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guillain-Barré syndrome of axonal type, Campylobacter jejuni infection and anti-ganglioside GM1 antibodies].
    Attarian S; Bonnefoi-Kyriacou B; Gayraud D; Mignard P; Boucraut J; Pouget J; Viallet F
    Rev Neurol (Paris); 1997 Apr; 153(3):205-8. PubMed ID: 9296136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni enteritis].
    Tsuda N; Negoro K; Morimatsu M; Saito K; Yuki N
    Rinsho Shinkeigaku; 1995 Feb; 35(2):208-10. PubMed ID: 7781242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
    Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
    Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
    J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
    Yuki N
    Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain-Barré syndrome and Campylobacter jejuni: a serological study.
    Kaldor J; Speed BR
    Br Med J (Clin Res Ed); 1984 Jun; 288(6434):1867-70. PubMed ID: 6428580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT.
    Hagensee ME; Benyunes M; Miller JA; Spach DH
    Bone Marrow Transplant; 1994 Mar; 13(3):349-51. PubMed ID: 8199580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
    Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
    Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barre syndrome and Campylobacter infection.
    Prasad KN; Pradhan S; Nag VL
    Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):527-30. PubMed ID: 11944711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fisher's syndrome following Campylobacter jejuni enteritis--a case report and review of the literature].
    Ichikawa H; Sugita K; Fukui T; Saito K; Yuki N
    Rinsho Shinkeigaku; 1995 Apr; 35(4):391-5. PubMed ID: 7614765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain-Barré syndrome.
    Sinha S; Prasad KN; Pradhan S; Jain D; Jha S
    Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):342-6. PubMed ID: 15099989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.
    Takahashi M; Koga M; Yokoyama K; Yuki N
    J Clin Microbiol; 2005 Jan; 43(1):335-9. PubMed ID: 15634991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
    Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP
    Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
    Prendergast MM; Moran AP
    J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Shinkeigaku; 1999 Jan; 39(1):17-8. PubMed ID: 10377788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
    Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
    J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Axonal Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni (PEN 43) enteritis].
    Ihara Y; Saito K; Yoshimoto S; Hayabara T; Yuki N
    Rinsho Shinkeigaku; 1995 Aug; 35(8):901-3. PubMed ID: 8665735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.